Evolus (EOLS) Net Margin (2019 - 2026)

Evolus (EOLS) reported Net Margin of 14.59% for Q1 2026, up 1298.0% on a YoY basis from 1.04% in Q1 2025, and down 10237.58% quarter-over-quarter from 0.14% in Q4 2025.

Evolus (EOLS) Net Margin (2019 - 2026) Analysis & Trends

Evolus has reported Net Margin for 8 years, with the latest figure at 14.59% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin rose 1298.0% year-over-year to 14.59%; the trailing twelve-month figure through Mar 2026 stood at 14.39% (up 601.0% YoY), and the FY2025 full-year result was 17.38%, up 156.0% from the prior year.
  • Net Margin for Q1 2026 stood at 14.59%, down from 0.14% in the prior quarter.
  • The five-year high for Net Margin was 0.14% in Q4 2025, with the low at 63.16% in Q2 2022.
  • Historically, Net Margin has averaged 29.34% across 5 years, with a median of 27.57% in 2025.
  • Annual changes were most pronounced in 2022 — Net Margin sank 10390 bps — and 2023, when it surged 2640 bps.
  • Evolus' Net Margin stood at 30.16% in 2022, then soared by 36 bps to 19.4% in 2023, then soared by 56 bps to 8.6% in 2024, then soared by 102 bps to 0.14% in 2025, then plunged by 10238 bps to 14.59% in 2026.
  • The last three Net Margin figures came in at 14.59% (Q1 2026), 0.14% (Q4 2025), and 22.82% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 9.19%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 26.57%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 35.18%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 2.94%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 24.30%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 4.16%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -168.42%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 31.38%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -15.15%
10 Evolus 435.45 Mn 385.65 Mn 48.90 Mn -14.59%

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.59%
Dec 31, 2025 0.14%
Sep 30, 2025 -22.82%
Jun 30, 2025 -24.70%
Mar 31, 2025 -27.57%
Dec 31, 2024 -8.60%
Sep 30, 2024 -31.38%
Jun 30, 2024 -16.96%
Mar 31, 2024 -22.09%
Dec 31, 2023 -19.40%
Sep 30, 2023 -33.83%
Jun 30, 2023 -36.76%
Mar 31, 2023 -35.45%
Dec 31, 2022 -30.16%
Sep 30, 2022 -59.81%
Jun 30, 2022 -63.16%
Mar 31, 2022 -51.61%
Dec 31, 2021 -52.45%
Sep 30, 2021 -72.85%
Jun 30, 2021 -59.78%